## **Core Concept**
Neuroendocrine tumors (NETs) are neoplasms that arise from cells of the endocrine (hormonal) and nervous systems. They can express various markers that help in their identification and classification. Common markers for NETs include chromogranin A, synaptophysin, and CD56 (NCAM).

## **Why the Correct Answer is Right**
CD56, also known as Neural Cell Adhesion Molecule (NCAM), is indeed expressed by neuroendocrine tumors, as are chromogranin A and synaptophysin, which are well-established markers for these tumors. On the other hand, **cytokeratin 7 (CK7)** is not typically expressed by neuroendocrine tumors. CK7 is more commonly associated with carcinomas of the lung, thyroid, and breast, among others.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Chromogranin A is a marker commonly expressed by neuroendocrine tumors, making it incorrect as an answer to this question.
- **Option B:** Synaptophysin is another marker typically expressed by neuroendocrine tumors, which makes this option incorrect.
- **Option D:** CD56 (NCAM) is expressed by neuroendocrine tumors, particularly useful in identifying certain types like small cell lung carcinoma and Merkel cell carcinoma, making this option incorrect.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that neuroendocrine tumors often express a combination of markers including chromogranin A, synaptophysin, and CD56. However, the absence of CK7 and CK20 can help differentiate NETs from other carcinomas, especially in cases where the diagnosis is uncertain.

## **Correct Answer:** . Cytokeratin 7 (CK7)